As PRMT5 was overexpressed in all tested CD34+CD15− CP-CML samples, it could be a candidate biomarker of CP-CML stem/progenitor cells (Figure 1). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.